Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.
Shah NN, Ahn KW, Litovich C, Sureda A, Kharfan-Dabaja MA, Awan FT, Ganguly S, Gergis U, Inwards D, Karmali R, Lazaryan A, Lekakis L, Munshi P, Nathan S, Saad AA, Solh M, Steinberg A, Vij R, Wood WA, Fenske TS, Smith S, Hamadani M. Shah NN, et al. Among authors: lazaryan a. Blood Cancer J. 2019 Dec 3;9(12):97. doi: 10.1038/s41408-019-0261-1. Blood Cancer J. 2019. PMID: 31796726 Free PMC article.
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.
Shah NN, Ahn KW, Litovich C, Sureda A, Kharfan-Dabaja MA, Awan FT, Ganguly S, Gergis U, Inwards D, Karmali R, Lazaryan A, Lekakis L, Munshi P, Nathan S, Saad AA, Solh M, Steinberg A, Vij R, Wood WA, Fenske TS, Smith S, Hamadani M. Shah NN, et al. Among authors: lazaryan a. Blood Cancer J. 2021 Apr 29;11(4):82. doi: 10.1038/s41408-021-00472-w. Blood Cancer J. 2021. PMID: 33927193 Free PMC article. No abstract available.
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant.
Elmariah H, Kim J, Gonzalez R, DiMaggio E, Sansil S, Yoder S, Mishra A, Faramand R, Perez L, Lazaryan A, Mirza AS, Khimani F, Liu H, Ochoa-Bayona JL, Nieder M, Perna F, Figura N, Robinson TJ, Nishihori T, Anasetti C, Pidala JA, Bejanyan N. Elmariah H, et al. Among authors: lazaryan a. Am J Hematol. 2025 Jun 10. doi: 10.1002/ajh.27738. Online ahead of print. Am J Hematol. 2025. PMID: 40492500 No abstract available.
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis.
Mehta RS, Aljawai YM, Al-Juhaishi T, Saultz J, Milano F, Kanakry JA, Kanakry CG, Lazaryan A. Mehta RS, et al. Among authors: lazaryan a. Transplant Cell Ther. 2025 May 14:S2666-6367(25)01170-4. doi: 10.1016/j.jtct.2025.05.005. Online ahead of print. Transplant Cell Ther. 2025. PMID: 40379049
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.
Mokhtari S, Asquith JM, Kareem SS, Bachmeier CA, Pina Y, Faramand RG, Kim Y, Peguero EN, Sahebjam S, Jaffer MH, Iacono DP, Jain MD, Vogelbaum MA, Davila ML, Forsyth PA, Locke FL, Lazaryan A. Mokhtari S, et al. Among authors: lazaryan a. Int J Mol Sci. 2025 Apr 21;26(8):3904. doi: 10.3390/ijms26083904. Int J Mol Sci. 2025. PMID: 40332772 Free PMC article.
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.
Jhaveri K, Thapa R, Ercan D, Saha A, Noble J, Singh P, Fahrmann J, Saini N, Wu R, Dennison JB, Hanash S, Jenq RR, Modi K, Figura N, Chavez J, Shah B, Nishihori T, Lazaryan A, Khimani F, Bachmeier C, Gage K, Mishra A, Perna F, Davila ML, Spiegel J, Rejeski K, Subklewe M, Locke FL, Freeman C, Parker N, Jain MD. Jhaveri K, et al. Among authors: lazaryan a. Clin Cancer Res. 2025 Jul 1;31(13):2756-2766. doi: 10.1158/1078-0432.CCR-24-3782. Clin Cancer Res. 2025. PMID: 40238583
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation.
Mehta RS, Choe H, Saultz J, Gong Z, Sharma P, Al-Juhaishi T, Petitto GS, Lazaryan A, Singh A, Xue E, Dimitrova D, Hyder M, McCurdy S, Im A, Huber B, Aljawai YM, Kanakry J, Milano F, Kanakry CG. Mehta RS, et al. Among authors: lazaryan a. Am J Hematol. 2025 Jun;100(6):987-997. doi: 10.1002/ajh.27662. Epub 2025 Mar 12. Am J Hematol. 2025. PMID: 40071498
Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients.
Adoncecchi G, Kumar A, Mogili K, Faramand R, Liu H, Khimani F, Mishra A, Nieder M, Nishihori T, Hansen D, Jain M, Lazaryan A, Perez L, Pidala J, Locke F, Anasetti C, Bejanyan N, Elmariah H. Adoncecchi G, et al. Among authors: lazaryan a. Cancers (Basel). 2025 Jan 19;17(2):310. doi: 10.3390/cancers17020310. Cancers (Basel). 2025. PMID: 39858092 Free PMC article.
122 results